Figure 3.

Measurement of serum TFF3 levels in colorectal cancer patients. Serum TFF3 levels were compared in colorectal cancer patients. The significant ratios with P < 0.05 between 2 groups (clinical stage III/IV) and another 2 groups (clinical stage I-II/IV) (a) The significant ratios with P < 0.05 between 2 groups M0 (patients without distant metastasis) and M1 (patients with distant metastasis) (b), lymphatic metastasis after excluding the interference of distant metastasis (d),The significant ratios with P < 0.05 between 2 groups (age >60 y and age ≤60 y) (c) and another 2 groups (N1 and N2) number of lymphatic metastases (e).

Xiao et al. BMC Clinical Pathology 2014 14:26   doi:10.1186/1472-6890-14-26
Download authors' original image